These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

328 related items for PubMed ID: 17302879

  • 21. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 22. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
    Labrie F, Bélanger A, Cusan L, Candas B.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
    [Abstract] [Full Text] [Related]

  • 23. Dehydroepiandrosterone replacement in women with adrenal insufficiency.
    Arlt W, Callies F, van Vlijmen JC, Koehler I, Reincke M, Bidlingmaier M, Huebler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    N Engl J Med; 1999 Sep 30; 341(14):1013-20. PubMed ID: 10502590
    [Abstract] [Full Text] [Related]

  • 24. Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women.
    Dhatariya K, Bigelow ML, Nair KS.
    Diabetes; 2005 Mar 30; 54(3):765-9. PubMed ID: 15734854
    [Abstract] [Full Text] [Related]

  • 25. Androgen therapy with dehydroepiandrosterone.
    Buvat J.
    World J Urol; 2003 Nov 30; 21(5):346-55. PubMed ID: 14551720
    [Abstract] [Full Text] [Related]

  • 26. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
    Forsblad-d'Elia H, Carlsten H, Labrie F, Konttinen YT, Ohlsson C.
    J Clin Endocrinol Metab; 2009 Jun 30; 94(6):2044-51. PubMed ID: 19318446
    [Abstract] [Full Text] [Related]

  • 27. Effects of short-term DHEA intake on hormonal responses in young recreationally trained athletes: modulation by gender.
    Collomp K, Buisson C, Gravisse N, Belgherbi S, Labsy Z, Do MC, Gagey O, Dufay S, Vibarel-Rebot N, Audran M.
    Endocrine; 2018 Mar 30; 59(3):538-546. PubMed ID: 29322301
    [Abstract] [Full Text] [Related]

  • 28. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial.
    Johannsson G, Burman P, Wirén L, Engström BE, Nilsson AG, Ottosson M, Jonsson B, Bengtsson BA, Karlsson FA.
    J Clin Endocrinol Metab; 2002 May 30; 87(5):2046-52. PubMed ID: 11994339
    [Abstract] [Full Text] [Related]

  • 29. The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.
    Zimmerman Y, Coelingh Bennink HJ, Wouters W, Ebes F, Fauser BC.
    Eur J Contracept Reprod Health Care; 2013 Dec 30; 18(6):489-500. PubMed ID: 23944295
    [Abstract] [Full Text] [Related]

  • 30. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
    Young J, Couzinet B, Nahoul K, Brailly S, Chanson P, Baulieu EE, Schaison G.
    J Clin Endocrinol Metab; 1997 Aug 30; 82(8):2578-85. PubMed ID: 9253337
    [Abstract] [Full Text] [Related]

  • 31. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul 30; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

  • 32. Intravenous lipid and heparin infusion-induced elevation in free fatty acids and triglycerides modifies circulating androgen levels in women: a randomized, controlled trial.
    Mai K, Bobbert T, Reinecke F, Andres J, Maser-Gluth C, Wudy SA, Möhlig M, Weickert MO, Hartmann MF, Schulte HM, Diederich S, Pfeiffer AF, Spranger J.
    J Clin Endocrinol Metab; 2008 Oct 30; 93(10):3900-6. PubMed ID: 18664538
    [Abstract] [Full Text] [Related]

  • 33. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
    Labrie F, Bélanger A, Cusan L, Gomez JL, Candas B.
    J Clin Endocrinol Metab; 1997 Aug 30; 82(8):2396-402. PubMed ID: 9253307
    [Abstract] [Full Text] [Related]

  • 34. Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.
    Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.
    Contraception; 2015 Feb 30; 91(2):134-42. PubMed ID: 25496917
    [Abstract] [Full Text] [Related]

  • 35. Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
    Morales AJ, Nolan JJ, Nelson JC, Yen SS.
    J Clin Endocrinol Metab; 1994 Jun 30; 78(6):1360-7. PubMed ID: 7515387
    [Abstract] [Full Text] [Related]

  • 36. Effect of dehydroepiandrosterone replacement on lipoprotein profile in hypoadrenal women.
    Srinivasan M, Irving BA, Dhatariya K, Klaus KA, Hartman SJ, McConnell JP, Nair KS.
    J Clin Endocrinol Metab; 2009 Mar 30; 94(3):761-4. PubMed ID: 19066301
    [Abstract] [Full Text] [Related]

  • 37. Effects of dehydroepiandrostenedione, superimposed on growth hormone substitution, on quality of life and insulin-like growth factor I in patients with secondary adrenal insufficiency: a randomized, placebo-controlled, cross-over trial.
    van Thiel SW, Romijn JA, Pereira AM, Biermasz NR, Roelfsema F, van Hemert A, Ballieux B, Smit JW.
    J Clin Endocrinol Metab; 2005 Jun 30; 90(6):3295-303. PubMed ID: 15797966
    [Abstract] [Full Text] [Related]

  • 38. Long-term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial.
    Gurnell EM, Hunt PJ, Curran SE, Conway CL, Pullenayegum EM, Huppert FA, Compston JE, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2008 Feb 30; 93(2):400-9. PubMed ID: 18000094
    [Abstract] [Full Text] [Related]

  • 39. Anti-interleukin-6 receptor antibody therapy favors adrenal androgen secretion in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled study.
    Straub RH, Härle P, Yamana S, Matsuda T, Takasugi K, Kishimoto T, Nishimoto N.
    Arthritis Rheum; 2006 Jun 30; 54(6):1778-85. PubMed ID: 16729287
    [Abstract] [Full Text] [Related]

  • 40. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
    Munarriz R, Talakoub L, Flaherty E, Gioia M, Hoag L, Kim NN, Traish A, Goldstein I, Guay A, Spark R.
    J Sex Marital Ther; 2002 Jun 30; 28 Suppl 1():165-73. PubMed ID: 11898698
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.